Objectives: Periodontitis is a chronic inflammatory disease induced by periodontal disease-causing bacteria. It has been shown that excessive immune response against bacteria is involved in periodontal tissue destruction including alveolar bone resorption. Erucin is a biologically active substance found in cruciferous plants such as arugula and is classified as an isothiocyanate. No previous studies have attempted to use erucin in the treatment of periodontitis, and there are no papers that have examined the effects of erucin on periodontal resident cells. The purpose of this study was to analyze the effects of erucin on the production of inflammatory and antioxidant mediators produced by tumor necrosis factor (TNF)-α-stimulated TR146 cells, an oral epithelial cell line, including its effects on signaling molecules.

Methods: Cytokine and chemokine levels were measured by ELISA. Protein expression in TR146 cells and activations of signal transduction pathway were determined by Western blotting.

Results: Our results indicate that erucin suppresses interleukin-6 and CXC-chemokine ligand 10 production and vascular cell adhesion molecule-1 expression in TNF-α-stimulated TR146 cells. In addition, erucin induced the production of the antioxidant enzymes, Heme Oxygenase-1 and NAD(P)H quinone dehydrogenase 1 in TR146 cells. Furthermore, erucin suppressed TNF-α-stimulated nuclear factor-κB, signal transducer and activator of transcription3, and phospho-70S6 Kinase-S6 ribosomal protein signaling pathways in TR146 cells. We have shown that erucin has anti-inflammatory effects on oral epithelial cells and also induces the production of antioxidant mediators.

Conclusions: These results suggest that erucin may provide a new anti-inflammatory agent that can be used in the treatment of periodontitis.

Download full-text PDF

Source
http://dx.doi.org/10.1080/08923973.2023.2250551DOI Listing

Publication Analysis

Top Keywords

tr146 cells
20
effects erucin
12
oral epithelial
12
erucin
9
expression tnf-α-stimulated
8
cells
8
epithelial cells
8
treatment periodontitis
8
tnf-α-stimulated tr146
8
production antioxidant
8

Similar Publications

Design, additive manufacturing, and characterization of an organ-on-chip microfluidic device for oral mucosa analogue growth.

J Mech Behav Biomed Mater

December 2024

Department of Prosthodontics, Dental and Craniofacial Bioengineering and Applied Biomaterials, School of Dentistry, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece. Electronic address:

Introduction: Α customized organ-on-a-chip microfluidic device was developed for dynamic culture of oral mucosa equivalents (Oral_mucosa_chip-OMC).

Materials And Methods: Additive Manufacturing (AM) was performed via stereolithography (SLA) printing. The dimensional accuracy was evaluated via microfocus computed tomography (mCT), the surface characteristics via scanning electron microscopy (SEM), while the mechanical properties via nanoindentation and compression tests.

View Article and Find Full Text PDF

Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25CD163CD206 macrophages.

Oral Oncol

December 2024

Department of Immunology, Ophthalmology and ORL, School of Medicine, Complutense University of Madrid, Pza Ramon y Cajal, s/n, 28040 Madrid, Spain. Electronic address:

Article Synopsis
  • Tumor-associated macrophages (TAMs) play a significant role in the tumor microenvironment of oral squamous cell carcinomas (OSCCs) and primarily originate from circulating monocytes that differentiate locally.
  • Research showed that cell culture media from OSCC cell lines, H413 and TR146, encourages monocytes to become M2 macrophages, which are characterized by high CD163 and CD206 expression and low levels of activation markers.
  • Additionally, the study identified specific soluble proteins in the media that promote this differentiation and linked it to an immunosuppressive profile that hinders T cell activation, shedding light on how OSCCs support tumor growth by altering immune cell behavior.
View Article and Find Full Text PDF
Article Synopsis
  • Candidalysin, produced by Candida albicans, is a virulence factor that damages host cells, and this study identified specific genes related to glycosaminoglycan (GAG) biosynthesis that, when disrupted, confer resistance to this damage.
  • Researchers found that candidalysin binds to sulfated GAGs on the host cell surface, which helps it to cause damage, but adding exogenous sulfated GAGs like dextran sulfate can protect cells and inhibit candidalysin's effects.
  • In a mouse model of vulvovaginal candidiasis, applying dextran sulfate reduced tissue damage and inflammation, suggesting sulfated GAGs are potential therapeutic targets to counteract candidalysin-related damage.
View Article and Find Full Text PDF

Platelet-rich fibrin (PRF), originally used to support soft tissue healing, is also considered a therapeutic option for treating oral lichen planus and leukoplakia. The progression from the two premalignant lesions to the aggressive malignant oral squamous cell carcinoma involves an inflammatory process linked to chemokine expression. Thus, there is a rationale for studying how PRF modulates the expression of chemokines in oral squamous carcinoma cells.

View Article and Find Full Text PDF

The formulation and delivery of macromolecules through the oral route pose considerable challenges due to factors such as large molecular weight, pH sensitivity, and limited formulation approaches. This challenge is compounded if the drug is poorly permeable, necessitating innovative drug delivery strategies. Vancomycin, a widely prescribed glycopeptide antibiotic, has an oral bioavailability of less than 10%, leading to predominantly intravenous administration and potential patient discomfort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!